Detalles de la búsqueda
1.
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry.
J Pathol
; 260(1): 5-16, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36656126
2.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658905
3.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Exp Mol Pathol
; 131: 104860, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997051
4.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938166
5.
Subjective Outcome after Discontinuation of Botulinum Toxin-A Detrusor Injection for Lower Urinary Tract Disorders: The Majority Suffers!
Urol Int
; 107(3): 263-272, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717940
6.
A non-inferiority comparative analysis of micro-ultrasonography and MRI-targeted biopsy in men at risk of prostate cancer.
BJU Int
; 129(5): 648-654, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34773679
7.
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset.
BJU Int
; 130(6): 754-763, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928524
8.
Transurethral suturing of bladder following transurethral excision of female vesico-urachal diverticula: a novel technique with long-term follow-up results.
Clin Exp Nephrol
; 26(11): 1137-1143, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819651
9.
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Int J Mol Sci
; 23(14)2022 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35887247
10.
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer.
Int J Cancer
; 148(3): 748-758, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045100
11.
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.
Int J Cancer
; 147(2): 575-583, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150281
12.
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
Prostate
; 80(13): 1097-1107, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32628300
13.
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.
Br J Cancer
; 123(4): 604-609, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467601
14.
EGFR as a stable marker of prostate cancer dissemination to bones.
Br J Cancer
; 123(12): 1767-1774, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32901137
15.
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach.
Am J Transplant
; 20(7): 1826-1836, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323460
16.
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
Mol Med
; 26(1): 24, 2020 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32143573
17.
Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer.
Clin Chem
; 66(1): 161-168, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601564
18.
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
BMC Cancer
; 20(1): 1220, 2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33339518
19.
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
World J Urol
; 38(9): 2185-2196, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31745645
20.
The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Psychooncology
; 29(8): 1338-1346, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539186